Examine individual changes

'{{dablink|This article deals exclusively with applications of antiserum. For an explanation of its production, see "[[polyclonal antibodies]]".}} '''Antiserum''' (plural: antisera) is [[blood serum]] containing [[polyclonal response|polyclonal]] [[antibodies]]. Antiserum is used to pass on passive [[immunity (medical)|immunity]] to many diseases. Passive antibody transfusion from a previous human survivor is the only known effective treatment for [[Ebola]] infection (but with little success rate).<ref>Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, Kipasa M, Colebunders R, Muyembe-Tamfum JJ. 1999. Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients. The Journal of Infectious Diseases 179(suppl 1):S18-23.~~~~</ref> The most common use of antiserum in humans is as [[antitoxin]] or [[antivenom]], to treat [[envenomation]]. == How it works == Antibodies in the antiserum bind the infectious agent or antigen. The immune system then recognizes foreign agents bound to antibodies and triggers a more robust immune response. The use of antiserum is particularly effective against pathogens which are capable of evading the immune system in the unstimulated state but which are not robust enough to evade the stimulated immune system. The existence of antibodies to the agent therefore depends on an initial "lucky survivor" whose immune system by chance discovered a counteragent to the pathogen, or a "host species" which carries the virus but does not suffer from its effects. Further stocks of antiserum can then be produced from the initial donor or from a donor organism that is inoculated with the pathogen and cured by some stock of preexisting antiserum ==References== {{reflist}} ==External links== * {{MeshName|Antisera}} ==Further reading== *Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, Kipasa M, Colebunders R, Muyembe-Tamfum JJ. 1999. Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients. The Journal of Infectious Diseases 179(suppl 1):S18-23. {{Immune sera and immunoglobulins}} [[Category:Blood]] {{immunology-stub}} [[ca:Seroteràpia]]'